These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34887959)

  • 1. Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter-defibrillator.
    Yang PS; Kang Y; Bae HJ; Sung JH; Park HD; Joung B
    J Arrhythm; 2021 Dec; 37(6):1537-1545. PubMed ID: 34887959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes after placement of an implantable cardioverter-defibrillator: does the etiology of heart failure matter?
    Wasiak M; Tajstra M; Pyka Ł; Gąsior M
    Kardiol Pol; 2020 Apr; 78(4):318-324. PubMed ID: 32200617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Thøgersen AM; Videbæk L; Bruun NE; Eiskjær H; Haarbo J; Egstrup K; Gustafsson F; Hastrup Svendsen J; Høfsten DE; Pehrson S; Nielsen JC; Køber L; Thune JJ
    Circ Heart Fail; 2019 Sep; 12(9):e006022. PubMed ID: 31500444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure.
    Nomoto M; Suzuki A; Shiga T; Shoda M; Hagiwara N
    BMC Cardiovasc Disord; 2022 Aug; 22(1):374. PubMed ID: 35974317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Models for Prediction of Implantable Cardioverter-Defibrillator Benefit: Insights From the DANISH Trial.
    Kristensen SL; Levy WC; Shadman R; Nielsen JC; Haarbo J; Videbæk L; Bruun NE; Eiskjær H; Wiggers H; Brandes A; Thøgersen AM; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Signorovitch J; Køber L; Thune JJ
    JACC Heart Fail; 2019 Aug; 7(8):717-724. PubMed ID: 31302052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis.
    Rohde LE; Chatterjee NA; Vaduganathan M; Claggett B; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    JACC Heart Fail; 2020 Oct; 8(10):844-855. PubMed ID: 32919916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.
    Elming MB; Nielsen JC; Haarbo J; Videbæk L; Korup E; Signorovitch J; Olesen LL; Hildebrandt P; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Videbæk R; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Thune JJ
    Circulation; 2017 Nov; 136(19):1772-1780. PubMed ID: 28877914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
    Briongos-Figuero S; Estévez A; Luisa Pérez M; Martínez-Ferrer JB; García E; Viñolas X; Arenal Á; Alzueta J; Basterra N; Rodríguez A; Lozano I; Muñoz-Aguilera R
    Int J Cardiol; 2019 Jan; 274():163-169. PubMed ID: 30206014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease.
    Smith T; Theuns DA; Caliskan K; Jordaens L
    Clin Cardiol; 2011 Dec; 34(12):761-7. PubMed ID: 22038531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality).
    Yafasova A; Butt JH; Elming MB; Nielsen JC; Haarbo J; Videbæk L; Olesen LL; Steffensen FH; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Egstrup K; Gustafsson F; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circulation; 2022 Feb; 145(6):427-436. PubMed ID: 34882430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NT-proBNP and ICD in Nonischemic Systolic Heart Failure: Extended Follow-Up of the DANISH Trial.
    Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    JACC Heart Fail; 2022 Mar; 10(3):161-171. PubMed ID: 35241243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosis.
    Byrne C; Ahlehoff O; Elming MB; Pedersen F; Pehrson S; Nielsen JC; Eiskjaer H; Videbaek L; Svendsen JH; Haarbo J; Thøgersen AM; Køber L; Thune JJ
    ESC Heart Fail; 2022 Apr; 9(2):1287-1293. PubMed ID: 35106935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up.
    Gandhi K; Aronow WS; Desai H; Amin H; Lai HM; Frishman WH; Cohen M; Sorbera C
    Arch Med Sci; 2010 Dec; 6(6):900-3. PubMed ID: 22427764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Implantable Cardioverter Defibrillator in Nonischemic Systolic Heart Failure According to Sex: Extended Follow-Up Study of the DANISH Trial.
    Butt JH; Yafasova A; Elming MB; Dixen U; Nielsen JC; Haarbo J; Videbæk L; Korup E; Bruun NE; Eiskjær H; Brandes A; Thøgersen AM; Gustafsson F; Egstrup K; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Thune JJ; Køber L
    Circ Heart Fail; 2022 Sep; 15(9):e009669. PubMed ID: 35942877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
    Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
    JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.
    Sharma A; Wu J; Xu H; Hernandez A; Felker GM; Al-Khatib S; Green J; Matsouaka R; Fonarow GC; Singh JP; Heidenreich PA; Ezekowitz JA; DeVore A
    J Am Heart Assoc; 2020 Jun; 9(12):e012405. PubMed ID: 32476539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Dickinson MG; Ip JH; Olshansky B; Hellkamp AS; Anderson J; Poole JE; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2007 Apr; 153(4):573-8. PubMed ID: 17383296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Implantable Cardioverter-defibrillators in Nonischemic Heart Failure According to Background Medical Therapy: Extended Follow-up of the DANISH Trial.
    Yafasova A; Doi SN; Thune JJ; Nielsen JC; Haarbo J; Bruun NE; Gustafsson F; Eiskjær H; Hassager C; Svendsen JH; Høfsten DE; Torp-Pedersen C; Pehrson S; Køber L; Butt JH
    J Card Fail; 2024 May; ():. PubMed ID: 38750689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality Benefit Among Primary Prevention Implantable Cardioverter-Defibrillator Recipients on Contemporary Heart Failure Treatment.
    Ahmed A; Auricchio A; Mittal S; Pickett RA; Wilkoff BL; Jacobsen LD; Marti AK; Holbrook RW; Soderlund DM; Curtis AB
    JACC Clin Electrophysiol; 2024 May; 10(5):916-926. PubMed ID: 38520434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.